Lucid Diagnostics LUCD Convertible Debt - Current
Convertible Debt - Current at other companies
Other financials
Where this comes from
Reported directly by Lucid Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:ConvertibleNotesPayableCurrent.
The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lucid Diagnostics's convertible debt - current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lucid Diagnostics's convertible debt - current?
- Lucid Diagnostics (LUCD) reported convertible debt - current of $25.2M in Q1 2026.
- How has Lucid Diagnostics's convertible debt - current changed year-over-year?
- Lucid Diagnostics's convertible debt - current decreased by 23.2% year-over-year, from $32.8M to $25.2M.
- What is the long-term trend for Lucid Diagnostics's convertible debt - current?
- Over 2 years (2023 to 2025), Lucid Diagnostics's convertible debt - current has grown at a 31.2% compound annual growth rate (CAGR), from $13.95M to $24M.
- What does convertible debt - current mean?
- This represents the portion of a company's total convertible debt obligations that is scheduled to mature or require repayment within the next twelve months. It serves as a critical indicator of near-term liquidity requirements and potential dilution risk if the debt is converted into equity rather than repaid in cash. Monitoring this balance helps investors assess the company's immediate financial obligations and its ability to manage capital structure transitions.